Browse every published article, from the latest research to earlier analysis. Use the page numbers below to explore the complete archive.
A case report described symptom control that allowed diagnostic testing. The benzodiazepine’s role was different from correcting the underlying cortisol disorder.
A mouse-cell study examined early developmental processes under drug exposure. Its molecular findings could not quantify birth-defect risk from a clinical prescription.
A zebrafish experiment found reduced injury markers after anesthetic pretreatment. Administration before arrest was different from rescue treatment after an unexpected clinical arrest.
A repurposing review discussed anticancer effects of midazolam in experimental systems. Those findings did not establish benefit from routine procedural sedation.
A mouse experiment found prolonged pentobarbital-induced sleep with selected extracts. Antagonist results suggested more than one possible pathway rather than a pure benzodiazepine-like effect.
A structure–activity study tested benzodiazepine-shaped compounds as potassium-channel activators. The chemical family name did not identify the biological target being investigated.
A pretreatment experiment found that seizure scores and tissue protection did not identify one uniformly superior compound. The ranking differed by brain region.
A review distinguished broad anesthesia findings from evidence about individual drug classes. Reassuring brief-exposure studies did not resolve every question about benzodiazepines.
A chemistry review described benzodiazepines as ligands for metal-containing compounds. Activity of a newly formed complex cannot be assigned automatically to its parent medicine.
A case described severe autonomic instability after an infected intrathecal system was removed. Symptomatic medicines including clonazepam did not adequately control the evolving presentation.
A small randomized eye-surgery study found that fewer pregabalin-treated patients needed intraoperative midazolam. Greater baseline sedation was also part of the observed treatment effect.
A biopsy-supported neurologic case favored a toxic cause of white-matter injury. Pathology did not identify benzodiazepines as the unique responsible exposure.
A laboratory study evaluated noninvasive temperature measurement during mild stress. Diazepam-sensitive temperature changes supported the method but did not create a clinical test for anxiety or intoxication.
A primary-care cohort described changes in diagnoses and initial treatment. Trends in recorded anxiety and benzodiazepine prescribing moved differently over the study period.
A case report described status epilepticus after fever following vaccination in a person with established epilepsy. The temporal sequence did not establish a population vaccine-risk estimate.
A schizophrenia-model study found that behavioral and receptor-binding outcomes diverged. Partial improvement after developmental diazepam exposure did not establish normalized receptor density.
A randomized study found lower postoperative inflammatory markers with dexmedetomidine than with midazolam. The biomarker findings did not establish that inflammation mediated every anxiety difference.
A cohort study associated sedative groups with cerebrospinal-fluid metabolic differences. Those patterns did not prove that a sedative caused a better or worse neurologic outcome.
A study of older inpatients found different screening totals under two versions of the Beers criteria. Benzodiazepines were a prominent flagged category, but a flag was not a documented injury.
A randomized veterinary trial compared opioid premedications in horses. Diazepam was part of the shared induction regimen rather than the randomized intervention.
A medicinal-chemistry study screened new compounds at several receptor targets. Binding activity and an anxiolytic-like behavioral result were distinct stages of the investigation.
A large ICU cohort found concurrent coded sedation and analgesia on most paralysis days. Its calendar-day data could not establish continuous coverage or prove awake paralysis.
A case report described persistent catatonia during several treatment attempts. A benzodiazepine’s presence in the earlier regimen did not establish a controlled test of the entire drug class.
A national practice survey described neonatal sedation in 2007. It found frequent use but limited written standardization, without comparing patient outcomes between drugs.
A rare-disease case described refractory seizures during multidrug treatment. Later improvement followed additional medicines, making a single-drug efficacy conclusion inappropriate.
A clinical experience report described successful procedures using a combined anesthesia strategy. It did not isolate midazolam’s effect or establish the absence of rare adverse events.
A Korean hospital study found frequent psychotropic ingestion among interviewed self-poisoning patients. Its sample excluded some of the most medically severe presentations.
An observational mother–infant study examined maximum weight loss after birth. Its benzodiazepine analyses concerned an additional exposure within an opioid-exposed population.
The MiND paper described a planned pharmacologic neuroimaging experiment. It did not report completed evidence that lorazepam restored younger patterns of brain activity in older adults.
A mouse study found that conditioned fear interfered with anxiety measurements. Diazepam’s effect depended on the experimental condition rather than appearing uniformly.